Related posts
Nervous markets await NvidiaTechnicals are very binary and clinical. So the setup is always there, but you don't know what the story is behind them. Trump is a bit of a wild card. But the underlying strength in the market (such as shown by the jobs numbers) means that investors are ready to buy on any weakness.
We've seen this a lot more with the Fed, where they're between a rock and a hard place. It was the last central bank to cut rates. The reason they dragged their feet, unlike Canada (which was one of the first of the G7 to lower rates), was concern that underlying strength of the US economy could come back to bite them.
In Canada, we may be less apt to lower if we see jobs continue to do well and GDP pick back up. If GDP starts to have some upward momentum, it'll put both central banks in a bit of a fix and we may not get those lower rates.
Looks good as a longer-term play, but it can be quite volatile. His team is now looking at positions and, for those that have done really well, deciding which ones to clip a bit to bring the position size back in line. Yesterday's pattern suggests further weakness to come, but it's not guaranteed.
Seeing a shorter-term reversal, where all the action of one day is encompassed by the next day's action. Yesterday it moved higher, but closed lower. Gold's up today because of the down market. No connection between safety and gold; biggest connection to gold is the USD.
While he may lighten up on the US dollar, he's not going to the ruble or the yuan. Chart on the USD starting to move up, and that's going to put some pressure on gold. Might see some people selling their gold and going back to the USD.
If you're gold's done well, maybe you clip some profits. But thematically, looks good long term. It's a balance of short term vs. long term.
Investing 101: Canadian Depositary Receipts (CDRs):
Canadian Depositary Receipts (CDRs) are a relatively new concept that has been introduced in recent years to help Canadians gain access to U.S. blue-chip stocks in a simplified, low-cost manner.
Canadian Depositary Receipts (CDRs) are securities that trade on the NEO Exchange in Canada, and the concepts are essentially similar to American Depository Receipts (ADRs) that are listed on American exchanges. CDRs give Canadians access to some of the largest US companies listed on NYSE and NASDAQ through a Canadian exchange in Canadian dollars. CDRs are issued and managed by the Canadian Imperial Bank of Commerce (CIBC). There are no management fees, so the main cost that investors will incur is the buy/sell commission on trades.
PROS:
Accessibility in registered accounts: CDRs can be held within registered accounts, similar to other Canadian-listed securities. We think CDRs can fit in any account, but generally, growth investments are usually better in a TFSA.
Currency-hedge feature: There is a currency-hedge built into the shares. That said, the built-in currency hedge has a certain cost and may not perfectly track changes in track exchange rate. There are no management fees associated with CDRs, but CIBC does make money on the currency hedge. While investors do not see this as a charge, it does impact net asset value. This cost is estimated to be about 0.50% annually.
The benefit of currency hedging could be explained through this example. For instance, if the Canadian dollar strengthens relative to the US dollar, then that investment will lag behind the equivalent US stock, and vice versa, if the US dollar appreciates, the CDR will appreciate more than the US equivalent. As investors might expect, this is simply a currency call.
Fractional ownership: One of the key advantages of CDRs is a lower share price. CDRs are structured so that the price per share always starts at $20, giving a wider array of investors access to these global companies. In simple terms, CDRs represent fractional interest in the underlying US shares.
CONS:
Illiquidity: The primary disadvantage of owning CDRs is their lower liquidity than the US shares. Consequently, a wider bid-ask spread could result in a higher cost when buying/selling for investors.
Withholding taxes still apply: Despite trading on Canadian exchanges, the underlying assets are still U.S. shares, which are subject to withholding taxes for dividends received (except in an RRSP account).
Limited selection: Since the product is still new, only a handful of well-known U.S. mega-cap stocks are currently available. Most small- and mid-cap U.S. companies are not yet offered as CDRs.
Conclusion
Overall, we are comfortable with CDRs for investors who want lower-priced exposure to U.S. securities with a built-in Canadian hedge. They are not fundamentally different from owning the underlying shares, aside from their price, the currency hedge, and where they trade. The underlying U.S. shares are held by CIBC, which issues the CDRs.
We generally prefer non-hedged products and would favour owning the U.S. shares directly if investors have the capital available and are comfortable with currency exposure. That said, we view CDRs as a good complementary option within a portfolio, and we would be comfortable buying them for U.S. company exposure.
Unlock Premium - Try 5i Free
We've had a fantastic run since the tariff tantrum back in March/April. Conditions still support further upside.
One of those is that we're expecting further rate cuts in the US, and likely one in Canada this month. As well, AI is still leading the group, but you have to be selective because things are getting a bit pricey.
And then we have very strong seasonality tailwinds behind us at this point. Q4 for the last 10 years has averaged about a 5.3% return, and it's been positive 9 of those 10 years. Finally, look at all the cash on the sidelines in the US -- about $7.3T. With interest rates coming down, some of that cash might move into equities and other risk assets including bonds.
Financials and technology. Likes healthcare for its combination of defense and growth. Some areas of healthcare have not performed well, such as big pharma. Whereas names in logistics and distribution have done well. So you need to be selective.
Pharma at this point is a bit of a value play. But with rates coming down, growth continues to be more of a favourite area. In a falling interest rate environment, growth tends to outperform.
He's not sure you'll find bargains per se. You can find some relative bargains among the larger-cap names if you look at not just the PE, but also the growth in front of them. Some of those names look good, while others have a very expensive PEG ratio. Again, you have to be very selective.
For growth, he looks for at least double-digit teens to maybe 20% earnings growth going forward. PEG ratios that are below 2 or 1.5.
We probably don't have as much dry powder waiting to be deployed. But gold has been performing very well, as has silver. He prefers silver, as it's outperformed gold this year. Banks have recovered very nicely so far this year.
When you look at the grand scheme of things, the US has more depth, different companies, and certainly more companies that are in the growth area. There are also opportunities beyond the NA borders.
In general, they have the opportunity to perform because the USD has been underperforming relative to the rest of the world (not including Canada). So you get the upside in the currencies of the international markets.
Certain international markets are cheaper than the US on a valuation perspective, no doubt about that. US is at high valuations. However, earnings growth continues to look good in the US. The aggregate earnings growth estimate for the S&P for 2026 is 12-13%, very conducive to more market upside.
A Comment -- General Comments From an Expert is a OTC stock, trading under the symbol A Commentary on the (). It is usually referred to as or A Commentary
In the last year, 3 stock analysts published opinions about A Commentary. 1 analyst recommended to BUY the stock. 1 analyst recommended to SELL the stock. The latest stock analyst recommendation is . Read the latest stock experts' ratings for A Comment -- General Comments From an Expert.
A Comment -- General Comments From an Expert was recommended as a Top Pick by on . Read the latest stock experts ratings for A Comment -- General Comments From an Expert.
Earnings reports or recent company news can cause the stock price to drop. Read stock experts’ recommendations for help on deciding if you should buy, sell or hold the stock.
3 stock analysts on Stockchase covered A Comment -- General Comments From an Expert In the last year. It is a trending stock that is worth watching.
On , A Comment -- General Comments From an Expert (A Commentary) stock closed at a price of $.